Rexulti 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL1GM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,956
Award facts
- Contract value 100% obligated
- $5,955.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,955.96 to Amerisourcebergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) on January 27, 2026, with an ultimate completion date of January 28, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is issued under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which functions as a comprehensive global pharmaceutical support vehicle.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The underlying IDC with DLA demonstrates the company's capability to efficiently fulfill government requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FL1GM?
SPE2DR26FL1GM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FL1GM worth?
The government has obligated $5,956 on SPE2DR26FL1GM.
Is contract SPE2DR26FL1GM an order under another contract?
Yes. SPE2DR26FL1GM is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL1GM competed?
The extent of competition for SPE2DR26FL1GM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award